Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K

Oncogene volume 24, pages 6796–6808 (2005)Cite this article

Abstract

Recent results have revealed that the p53 tumor suppressor protein possesses a direct transcription-independent apoptotic activity. During apoptosis induced by genotoxic stress, a small fraction of p53 is targeted to mitochondria where it initiates apoptosis by causing mitochondrial dysfunction. In adenovirus-infected cells, the expression of E1A protein enhances the accumulation of p53 during early phases of infection and during late times after infection, it is targeted for degradation by the combined action of E1B-55K and E4-orf6 proteins. The functional significance of E1A-mediated accumulation of p53 during early phases of viral replication is not known. Our studies with isogenic epithelial cell lines that differ only on the status of p53 indicate that Ad infection induces apoptosis by p53-dependent and -independent pathways and both pathways are suppressed by E1B-19K. We show that during early phase of Ad infection, a fraction of p53 is targeted to the mitochondria. In virus infected cells, a large fraction of the viral antiapoptosis protein E1B-19K is also localized in mitochondria during early and late phases of infection. Coimmunoprecipitation analysis has revealed that p53 and E1B-19K form a complex in mitochondria. The interaction of 19K involves two noncontiguous regions located around amino-acid residues 14–15 and 123–124. On p53, the mutations within the DNA-binding domain reduce interaction with E1B-19K. Our studies also suggest that 19K may additionally complex with the multidomain mitochondrial proapoptotic protein BAK, thereby reducing the level of p53 interaction with BAK. We suggest that p53-induced apoptosis may be important for efficient cell lysis and viral spread and that E1B-19K may neutralize the apoptotic activity of p53 at multiple levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Babiss LE, Fisher PB and Ginsberg HS . (1984). J. Virol., 49, 731–740.

  • Babiss LE and Ginsberg HS . (1984). J. Virol., 50, 202–212.

  • Bacchetti S and Graham FL . (1993). Int. J. Oncol., 3, 781–788.

  • Balint EE and Vousden KH . (2001). Br. J. Cancer, 85, 1813–1823.

  • Beck GR, Zerler BR and Moran E . (1998). Human Tumor Viruses McCance DJ (ed). Washington, DC: ASM Press, pp. 51–86.

    Book  Google Scholar 

  • Benard J, Douc-Rasy S and Ahomadegbe JC . (2003). Hum. Mutat., 21, 182–191.

  • Bett AJ, Krougliak V and Graham FL . (1995). Virus Res., 39, 75–82.

  • Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ and Chinnadurai G . (1995). Oncogene, 11, 1921–1928.

  • Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C and Chinnadurai G . (1994). Cell, 79, 341–351.

  • Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S and Chinnadurai G . (1993). EMBO J., 12, 469–478.

  • Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW and Vogelstein B . (1999). J. Clin. Invest., 104, 263–269.

  • Caelles C, Helmberg A and Karin M . (1994). Nature, 370, 220–223.

  • Chen G, Branton PE, Yang E, Korsmeyer SJ and Shore GC . (1996a). J. Biol. Chem., 271, 24221–24225.

  • Chen X, Ko LJ, Jayaraman L and Prives C . (1996b). Genes Dev., 10, 2438–2451.

  • Chinnadurai G . (1998). Semin. Virol., 8, 399–408.

  • Chiou SK, Tseng CC, Rao L and White E . (1994). J. Virol., 68, 6553–6566.

  • Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR . (2004). Science, 303, 1010–1014.

  • Chiou SK and White E . (1997). J. Virol., 71, 3515–3525.

  • Chipuk JE and Green DR . (2003). J. Clin. Immunol., 23, 355–361.

  • Chipuk JE, Maurer U, Green DR and Schuler M . (2003). Cancer Cell, 4, 371–381.

  • Collett D . (2003). Modelling Survival Data in Medical Research 2nd edn. Chapman & Hall/CRC: London/Boca Raton, FL.

    Google Scholar 

  • Collot-Teixeira S, Bass J, Denis F and Ranger-Rogez S . (2004). Rev. Med. Virol., 14, 301–319.

  • Crook T, Tidy JA and Vousden KH . (1991). Cell, 67, 547–556.

  • Cuconati A and White E . (2002). Genes Dev., 16, 2465–2478.

  • de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW . (1998). Genes Dev., 12, 2434–2442.

  • Debbas M and White E . (1993). Genes Dev., 7, 546–554.

  • Degenhardt K, Perez D and White E . (2000). Symp. Soc. Exp. Biol., 52, 241–251.

  • Dix BR, O'Carroll SJ, Myers CJ, Edwards SJ and Braithwaite AW . (2000). Cancer Res., 60, 2666–2672.

  • Dobner T, Horikoshi N, Rubenwolf S and Shenk T . (1996). Science, 272, 1470–1473.

  • Dumont P, Leu JI, Della Pietra III AC, George DL and Murphy M . (2003). Nat. Genet., 33, 357–365.

  • Erster S, Mihara M, Kim RH, Petrenko O and Moll UM . (2004). Mol. Cell. Biol., 24, 6728–6741.

  • Erster S and Moll UM . (2004). Cell Cycle, 3, 1492–1495.

  • Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC and Brown R . (1995). Nature, 374, 731–733.

  • Fu L, Minden MD and Benchimol S . (1996). EMBO J., 15, 4392–4401.

  • Gallimore PH and Turnell AS . (2001). Oncogene, 20, 7824–7835.

  • Grand RJ, Grant ML and Gallimore PH . (1994). Virology, 203, 229–240.

  • Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y and Livingston DM . (2003). Science, 300, 342–344.

  • Hale TK and Braithwaite AW . (1999). J. Biol. Chem., 274, 23777–23786.

  • Hall AR, Dix BR, O'Carroll SJ and Braithwaite AW . (1998). Nat. Med., 4, 1068–1072.

  • Han J, Sabbatini P, Perez D, Rao L, Modha D and White E . (1996a). Genes Dev., 10, 461–477.

  • Han J, Sabbatini P and White E . (1996b). Mol. Cell. Biol., 16, 5857–5864.

  • Harada JN, Shevchenko A, Pallas DC and Berk AJ . (2002). J. Virol., 76, 9194–9206.

  • Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M . (1995). Genes Dev., 9, 2170–2183.

  • Henry H, Thomas A, Shen Y and White E . (2002). Oncogene, 21, 748–760.

  • Hobom U and Dobbelstein M . (2004). J. Virol., 78, 7685–7697.

  • Hoffman WH, Biade S, Zilfou JT, Chen J and Murphy M . (2002). J. Biol. Chem., 277, 3247–3257.

  • Koch P, Gatfield J, Lober C, Hobom U, Lenz-Stoppler C, Roth J and Dobbelstein M . (2001). Cancer Res., 61, 5941–5947.

  • Kokontis JM, Wagner AJ, O'Leary M, Liao S and Hay N . (2001). Oncogene, 20, 659–668.

  • Lane DP and Crawford LV . (1979). Nature, 278, 261–263.

  • Leu JI, Dumont P, Hafey M, Murphy ME and George DL . (2004). Nat. Cell Biol., 6, 443–450.

  • Liang SH and Clarke MF . (2001). Eur. J. Biochem., 268, 2779–2783.

  • Linzer DI and Levine AJ . (1979). Cell, 17, 43–52.

  • Lomonosova E, Subramanian T and Chinnadurai G . (2002). J. Virol., 76, 11283–11290.

  • Lowe SW and Ruley HE . (1993). Genes Dev., 7, 535–545.

  • Mahyar-Roemer M, Fritzsche C, Wagner S, Laue M and Roemer K . (2004). Oncogene, 23, 6226–6236.

  • Marchenko ND, Zaika A and Moll UM . (2000). J. Biol. Chem., 275, 16202–16212.

  • Mathai JP, Germain M, Marcellus RC and Shore GC . (2002). Oncogene, 21, 2534–2544.

  • Michalovitz D, Halevy O and Oren M . (1990). Cell, 62, 671–680.

  • Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM . (2003). Mol. Cell, 11, 577–590.

  • Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB and Liu S . (2002). Oncogene, 21, 2613–2622.

  • Miyashita T and Reed JC . (1995). Cell, 80, 293–299.

  • Moll UM and Petrenko O . (2003). Mol. Cancer Res., 1, 1001–1008.

  • Moore M, Horikoshi N and Shenk T . (1996). Proc. Natl. Acad. Sci. USA, 93, 11295–11301.

  • Moran E . (1993). FASEB J., 7, 880–885.

  • Nakano K and Vousden KH . (2001). Mol. Cell, 7, 683–694.

  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N . (2000). Science, 288, 1053–1058.

  • Perfettini JL, Kroemer RT and Kroemer G . (2004). Nat. Cell Biol., 6, 386–388.

  • Petros AM, Gunasekera A, Xu N, Olejniczak ET and Fesik SW . (2004). FEBS Lett., 559, 171–174.

  • Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW and Branton PE . (2001a). Genes Dev., 15, 3104–3117.

  • Querido E, Marcellus RC, Lai A, Charbonneau R, Teodoro JG, Ketner G and Branton PE . (1997a). J. Virol., 71, 3788–3798.

  • Querido E, Morrison MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE and Morisson MR . (2001b). J. Virol., 75, 699–709.

  • Querido E, Teodoro JG and Branton PE . (1997b). J. Virol., 71, 3526–3533.

  • Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E . (1992). Proc. Natl. Acad. Sci. USA, 89, 7742–7746.

  • Sarnow P, Ho YS, Williams J and Levine AJ . (1982). Cell, 28, 387–394.

  • Shen Y, Kitzes G, Nye JA, Fattaey A and Hermiston T . (2001). J. Virol., 75, 4297–4307.

  • Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ and Bos JL . (1998). Oncogene, 16, 349–357.

  • Subramanian T and Chinnadurai G . (2003). J. Cell Biochem., 89, 1102–1114.

  • Subramanian T, Boyd JM and Chinnadurai G . (1995a). Oncogene, 11, 2403–2409.

  • Subramanian T, Kuppuswamy M, Mak S and Chinnadurai G . (1984). J. Virol., 52, 336–343.

  • Subramanian T, Tarodi B and Chinnadurai G . (1995b). Cell Growth Differ., 6, 131–137.

  • Subramanian T, Tarodi B, Govindarajan R, Boyd JM, Yoshida K and Chinnadurai G . (1993). Gene, 124, 173–181.

  • Tarodi B, Subramanian T and Chinnadurai G . (1993). Int. J. Oncol., 3, 467–472.

  • Teodoro JG and Branton PE . (1997). J. Virol., 71, 3620–3627.

  • Theodorakis P, D'Sa-Eipper C, Subramanian T and Chinnadurai G . (1996). Oncogene, 12, 1707–1713.

  • Theodorakis P, Lomonosova E and Chinnadurai G . (2002). Cancer Res., 62, 3373–3376.

  • Tollefson AE, Scaria A, Hermiston TW, Ryerse JS, Wold LJ and Wold WS . (1996). J. Virol., 70, 2296–2306.

  • Turnell AS, Grand RJ, Gorbea C, Zhang X, Wang W, Mymryk JS and Gallimore PH . (2000). EMBO J., 19, 4759–4773.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Vousden KH and Lu X . (2002). Nat. Rev. Cancer, 2, 594–604.

  • Wang G, Reed E and Li QQ . (2004). Oncol. Rep., 12, 955–965.

  • Webster GA and Perkins ND . (1999). Mol. Cell. Biol., 19, 3485–3495.

  • Werness BA, Levine AJ and Howley PM . (1990). Science, 248, 76–79.

  • White E, Blose SH and Stillman BW . (1984). Mol. Cell. Biol., 4, 2865–2875.

  • Wu Y, Mehew JW, Heckman CA, Arcinas M and Boxer LM . (2001). Oncogene, 20, 240–251.

  • Xu Y . (2003). Cell Death Differ., 10, 400–403.

  • Yew PR and Berk AJ . (1992). Nature, 357, 82–85.

  • Yew PR, Liu X and Berk AJ . (1994). Genes Dev., 8, 190–202.

  • Yu J, Wang Z, Kinzler KW, Vogelstein B and Zhang L . (2003). Proc. Natl. Acad. Sci. USA, 100, 1931–1936.

  • Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B . (2001). Mol. Cell, 7, 673–682.

Download references

Acknowledgements

This work was supported by a research grant (CA-33616) from the National Cancer Institute. We thank Vladimir Kurenok for help with data analysis. We also thank Bert Vogelstein, Frank Graham, Ute Moll, Pat Hearing and Peter Yaciuk for the gift of cells, virus and antibodies.

Author information

Authors and Affiliations

  1. Institute for Molecular Virology, Saint Louis University School of Medicine, 3681 Park Avenue, St Louis, 63110, MO, USA

    Elena Lomonosova, T Subramanian & G Chinnadurai

Authors
  1. Elena Lomonosova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Subramanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Chinnadurai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Chinnadurai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lomonosova, E., Subramanian, T. & Chinnadurai, G. Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K. Oncogene 24, 6796–6808 (2005). https://doi.org/10.1038/sj.onc.1208836

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208836

Keywords

This article is cited by

Search

Advanced search

Quick links